A new study has shown that inflation and rising living costs have severely affected access to essential diabetes medication in Nigeria, pushing many patients into financial hardship and worsening health outcomes.
The study, conducted by Development Governance International Consult (DGI Consult) with support from Gatefield, assessed the implications of inflation on access to antidiabetic drugs across the country.
Speaking during the World Diabetes Day Media Webinar tagged…
Read the full article here
